Surgeons Resolved Jaw Tumors Without Facial Surgery

Researchers successfully treated non-cancerous jaw lesions by addressing underlying parathyroid gland dysfunction.

Updated on Sept. 23, 2026 in Diabetes

Bold flat-color editorial illustration of a stylized parathyroid gland, evoking medical research and institutional systemic health.
Surgeons at Mohammed V University successfully treated rare jaw brown tumors by performing parathyroidectomies, addressing the underlying glandular hormone imbalance. AI Illustration. Upload story photo >

Live Poll

Would you seek diagnostic blood tests before consenting to surgery for an unexplained jaw growth?

Between 2022 and 2023, oral surgeons at Mohammed V University successfully treated three women for jaw brown tumors. Instead of performing facial surgery, medical teams corrected the patients' parathyroid gland dysfunction, which caused the lesions to regress.

Why it matters

Brown tumors are rare, non-cancerous bone complications caused by primary hyperparathyroidism, where overactive glands trigger bone-dissolving cells to leach calcium. By targeting the source of the hormone imbalance, doctors can eliminate the lesions without invasive facial procedures.

One patient exhibited a parathyroid hormone level of 2,062 pg/mL, while another reached 914.5 pg/mL. These findings represent a subset of the estimated 100,000 annual hyperparathyroidism cases diagnosed in the United States.

The players

Mohammed V University

This is a public research university located in Rabat, Morocco, where researchers conducted the retrospective analysis of the three patient cases.

The details

Doctors utilized 3D dental imaging and blood work to identify parathyroid adenomas as the root cause of the jaw lesions. Surgeons then performed a focused parathyroidectomy to remove the diseased neck glands, allowing the jaw tumors to heal naturally as hormone levels stabilized.

Timeline

  1. Three women were treated for jaw lesions between 2022 and 2023.

  2. A Tunisian study analyzed 16 patients with jaw tumors in 2023.

  3. A separate case was documented in Rawalpindi, Pakistan, in February 2026.

  4. The case series was published online on July 29, 2026.

  5. The findings appeared in the journal's print issue in September 2026.

The Big Picture

This study extends the findings established by the 2023 Tunisian study of 16 patients with jaw tumors by demonstrating the successful regression of lesions through targeted hormonal treatment.

Patients presenting with unusual jaw lesions may benefit from comprehensive blood work to check for hyperparathyroidism. If identified as the cause, surgeons may be able to resolve the issue through a gland-focused procedure rather than invasive oral surgery.

The takeaway

This research highlights the importance of diagnosing internal hormonal imbalances that can manifest as visible bone complications. By addressing the root endocrine disorder, patients can often avoid aggressive facial surgeries.

Further reading

Learn more about glandular health and related metabolic conditions in our Diabetes section.

Source note: This article includes information reported by Medical Daily.

Live Poll

Would you seek diagnostic blood tests before consenting to surgery for an unexplained jaw growth?